Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum

Cryptosporidiosis is an intestinal disease that affects a variety of hosts including animals and humans. Since no vaccines exist against the disease till date, drug treatment is the mainstay of disease control. Nitazoxanide (NTZ) is the only FDA-approved drug for the treatment of human cryptosporidi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen-Ho-Bao, Tran, Ambe, Lum A., Berberich, Maxi, Hermosilla, Carlos, Taubert, Anja, Daugschies, Arwid, Kamena, Faustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227457/
https://www.ncbi.nlm.nih.gov/pubmed/35745507
http://dx.doi.org/10.3390/pathogens11060653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227457/
https://www.ncbi.nlm.nih.gov/pubmed/35745507
http://dx.doi.org/10.3390/pathogens11060653

Ejemplares similares